The Next Move: Consequences For Emerging Markets

While this crisis will leave scars, it would be inaccurate to see only adversity ahead. Emerging markets can not only reclaim their hard-won economic gains, but do even better than before the pandemic. Obviously, a first step depends on procuring, producing and distributing vaccines to end this pandemic. Read More Here

Rate this:

China’s Inconvenient Truth

Xi Jinping is in a race against time. The glow of China’s early economic rebound and containment of COVID-19 is fading. The international media have moved on to celebrate vaccine efficacy and vaccination rates elsewhere, and other economies have started posting solid growth rates. Read Here | Foreign Affairs

Rate this:

China Seizes Vaccine Diplomacy Lead Over US

China contends that it is selflessly coming to the aid of the pandemic-stricken developing world by exporting nearly as much Covid-19 vaccine as it uses domestically. Along these lines, President Xi Jinping has branded Chinese-made vaccines as a “global public good.” Read Here | Asia Times

Rate this:

Who Should America Give Its Surplus Vaccines?

It’s that classic conundrum – the “good problem to have.” Well over a year into the pandemic, as Covid-19 continues its rampage across the globe and daily death tolls in nations such as Brazil and India soar to grim new records, the US suddenly finds itself in a fortunate position: It has a surplus of […]

Rate this:

Biden’s Misstep In India

The Biden administration’s announcement on Monday that it would soon export tens of millions of doses of the AstraZeneca vaccine completed a dramatic policy U-turn. It came after a tumultuous week in which the administration’s carefully constructed pandemic-diplomacy plan fell apart as the COVID-19 crisis in India worsened. Read Here | The Atlantic

Rate this: